HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-02-07FDA Approved: BIKTARVY — Original Application (Gilead Sciences, Inc.)
FDA approved Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) as a single-tablet regimen for the treatment of HIV-1 infection in a…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects [Phase 4]
Phase 4 trial update for DRIVESHAFT assessing darunavir/ritonavir in virologically suppressed HIV-infected experienced subjects; results pos…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Vitamin D Supplementation in HIV Youth [Phase 2, Phase 3]
A Phase 2/3 trial evaluating vitamin D supplementation in HIV-infected youth has completed enrollment and posted results.
-
FDA approval · 2018-02-01FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for EDURANT (rilpivirine hydrochloride) submitted by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Randomized Trial of an HIV Navigation Program for Early Palliative Care [Phase 2]
A Phase 2 randomized trial evaluating an HIV navigation program for early palliative care has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Strides Pharma Science Limited)
FDA approved the original application for tenofovir disoproxil fumarate as a generic product manufactured by Strides Pharma Science Limited.
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic Tenofovir disoproxil fumarate under an Original Application for use in HIV-1 infecti…
-
FDA approval · 2018-01-26FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved the original application for emtricitabine and tenofovir disoproxil fumarate as a generic product, manufactured by Quallent Pha…
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Tenofovir disoproxil fumarate from Aurobindo Pharma Limited, authorizing a generic version of the …
-
FDA approval · 2018-01-26FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Cipla USA Inc.)
FDA approved the original generic application for tenofovir disoproxil fumarate (Cipla USA Inc.), enabling a generic version of the HIV and …
-
FDA approval · 2018-01-25FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP, resulting in updated labeling for HIV…
-
FDA approval · 2018-01-25FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for PREZCOBIX (darunavir ethanolate and cobicistat) submitted by Janssen Products, LP, likely mo…
-
FDA approval · 2018-01-25FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP. The approval updates the product labe…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients. [Phase 4]
Phase 4 trial evaluating maraviroc for modulation of atherosclerosis in HIV patients; study completed.
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone [Phase 3]
A Phase 3 randomized, placebo-controlled trial evaluating prednisone to prevent TB-IRIS in high-risk HIV patients undergoing antiretroviral …
-
FDA approval · 2018-01-17FDA Approved: JULUCA — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for JULUCA (dolutegravir and rilpivirine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts [Phase 4]
Phase 4 trial comparing two antiretroviral regimens in treatment-naïve HIV-1 patients with low CD4 counts; completed.
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir [Phase 4]
Phase 4 trial update assessing FTC/RPV/TDF impact on T-cell activation, CD4+ T-cell counts, inflammatory biomarkers, and viral reservoir in …
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Sitagliptin for Reducing Inflammation and Immune Activation [Phase 2]
This update reports the completion of a Phase 2 trial evaluating sitagliptin to reduce inflammation and immune activation in HIV-1 infection…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART [Phase 2]
Phase 2 study assessing pharmacokinetic interactions between vaginal ring contraceptives and antiretroviral therapy in HIV-1 infection; resu…
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults [Phase 4]
Phase 4 trial comparing renal effects of Stribild and other tenofovir disoproxil fumarate regimens with ritonavir-boosted atazanavir plus ab…
-
CLINICAL_TRIALS trial_result · 2018-01-02Clinical Trial Update: Effect of Vitamin B on Plasma Neurofilament Light Protein (NFL) in HIV-infected Individuals With Increased Plasma Homocysteine [Phase 2]
Phase 2 clinical trial evaluating the effect of vitamin B on plasma neurofilament light protein in HIV-infected individuals with elevated ho…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis [Phase 2]
Phase II safety study and open-label demonstration of pre-exposure prophylaxis (PrEP) for HIV infection; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men [NA]
Clinical trial completed studying HIV/STD risk reduction among South African men; results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV [Phase 2]
Phase 2 clinical trial update on interventions for HIV-negative individuals with high-risk suspected exposure; study completed with results …